SPHERA FUNDS MANAGEMENT LTD. 13D and 13G filings for Outlook Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-10 5:28 pm Purchase |
2025-04-10 | 13G | Outlook Therapeutics, Inc. OTLK |
SPHERA FUNDS MANAGEMENT LTD. | 2,571,426 7.490% |
857,142 (+50.00%) |
Filing |
| 2025-03-03 3:58 pm Purchase |
2025-01-17 | 13G | Outlook Therapeutics, Inc. OTLK |
SPHERA FUNDS MANAGEMENT LTD. | 1,714,284 5.210% |
1,714,284 (New Position) |
Filing |